Latest news
One Blood Test for 50 Cancers Is Closer to the FDA. The Evidence Is Still Fighting Back.
An FDA advisory panel has backed GRAIL’s Galleri multi-cancer blood test for adults aged 50 and older. The vote could open a new era in cancer screening. It also exposes how unsettled the evidence remains over what “early detection” should actually prove.
Brain Cancer Finally Gets the PET Scan It Has Been Missing
Epilepsy Innovation Just Hit a Safety Wall
Heart calcium scans add little for most patients. Their real value may be in the uncertain middle
Obesity treatment is becoming a portfolio, not a product. Lilly’s EASD lineup shows what comes next
Medical AI can ace the benchmark and still fail the clinic. Real-world evidence is the next test
IPM Brief – Issue 30 | The Middle Powers Are Back in the Room – Is the Patient?
The Thymus May Be the Organ Radiation Oncology Forgot
Alzheimer’s PET Is Becoming Data Infrastructure
The Recall Is Still In The Freezer.
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.